company

KARO PHARMA INVEST AS

4848 ARENDAL

Return on Equity
93 %
Current Ratio
N/A
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue245 000
Net Income239 000
Total Assets258 000
Total Equity257 000
Income (NOK)2022
Revenue245 000
Expenditure6 000
Operating Profit239 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax239 000
Tax0
Net Income239 000
Balance (NOK)2022
Total Fixed Assets7 000
Total Current Assets251 000
Total Assets258 000
Total Retained Equity233 000
Total Equity257 000
Total Long-Term Debt1 000
Total Current Debt0
Total Equity and Debt258 000
Cash flow (NOK)2022
Sales Income0
Other Income245 000
Revenue245 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure6 000
Operating Profit239 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income239 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets7 000
Total Fixed Assets7 000
Stock0
Total Investments0
Cash, Bank6 000
Total Current Assets251 000
Total Assets258 000
Total Equity257 000
Short-Term Group Debt0
Total Long-Term Debt1 000
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt0
Total Current Debt0
Total Equity and Debt258 000
Financial indicators2022
Return on Equity93 %
Debt-to-Equity Ratio0
Operating Profit Margin97,55 %
Current Ratio-
Quick Ratio-
Equity Ratio1
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English